Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment

Inclusion Criteria: 1. Patients with more than two years without recurrence after curative treatment (surgery or local ablation) for HCC 2. Patients with no history of systemic treatment, radiation therapy, or trans-arterial chemoembolization for HCC 3. Older than 20 years of age 4. Eastern Cooperative Oncology Group performance status of 0-2 5. Patient is able to comply with scheduled visits, evaluation plans, and other study procedures 6. Patient is willing to provide written informed consent Exclusion Criteria: 1. Active or suspected cancer, or a history of malignancy where the risk of recurrence is equal or higher than 20% within 2 years. 2. Significant medical comorbidities in which survival is predicted to be less than 3 years 3. Estimated glomerular filtration rate \< 30 mL/min/1.73m² 4. Child-Pugh class C 5. Patient not eligible for applying LI-RADS criteria, such as Budd-Chiari Syndrome 6. Previous history of severe allergic reaction to iodine contrast medium 7. Precautions for MRI (cardiac pacemaker, severe claustrophobia that may interfere with protocol compliance). 8. Any other condition which, in the opinion of the Investigator, would make the patient unsuitable for enrollment or could interfere with completing the study.